The launch event will highlight IMID BioResource progress, include NIHR BioResource achievements and plans for the future.
NIHR BioResource
The NIHR BioResoure is a recallable resource of over 150,000 patients from a variety of common and rare diseases, and healthy volunteers. The BioResource provides access to these participants making research and development more efficient. With a single consent, repository and database, the BioResource samples and data have been developed to accelerate discovery in disease research. IMID BioResource is one of the common disease cohorts in the NIHR BioResource
NIHR IMID BioResource
The IMID (Immune Mediated Inflammatory Diseases) BioResource recruits patients with IMIDs including rheumatoid arthritis, psoriasis and connective tissue diseases. Both samples and data are collected and are held by the NIHR BioResource. IMID BioResource offers the advantage of a recallable resource to validate the discovery and delineation of novel and shared pathways and to facilitate planning of precision medicine interventions. IMID BioResource is a collaboration of northern NIHR Biomedical Research Centres – Manchester, Leeds and Newcastle, with Manchester being the lead site.
For further information, please contact the IMID Team:
Email: imid@manchester.ac.uk
Twitter: @IMIDBioResource
Venue: Virtual event - details will be sent to confirmed attendees
Programme
13:00 - Welcome - Maya Buch, The University of Manchester
13:10 - Case study – using a BioResource - Steve Eyre, The University of Manchester
13:25 - NIHR BioResource - Nathalie Kingston, NIHR BioResource
13:40 - Newcastle Dermatology - Nick Reynolds, Newcastle University
13:55 - Break
14:15 - Leeds Lupus - Ed Vital, University of Leeds
14:30 - Manchester Rheumatoid Arthritis - Maya Buch, The University of Manchester
14:45 - Industry - Monica Nijher, Pfizer
15:00 - Charity
15:15 - IMID BioResource vision for the future - Ian Bruce, CI IMID, The University of Manchester
15:30 – Close
